ZURICH: Swiss drugmaker Novartis on Monday offered to buy France’s Advanced Accelerator Applications (AAA) in a US$3.9 billion cash deal to strengthen the oncology portfolio at the world’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback